Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-22 5:19 pm Unchanged |
2021-07-02 | 13D | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 26,559,443 9.500% |
0 (Unchanged) |
Filing History |
| 2022-02-14 9:12 pm Purchase |
2021-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
PERCEPTIVE ADVISORS LLC | 4,849,912 9.800% |
672,191 (+16.09%) |
Filing History |
| 2022-02-14 9:10 pm Unchanged |
2021-12-31 | 13G | Quotient Limited QTNT |
PERCEPTIVE ADVISORS LLC | 405,020 15.800% |
0 (Unchanged) |
Filing History |
| 2022-02-14 9:01 pm Purchase |
2021-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
PERCEPTIVE ADVISORS LLC | 7,128,755 4.800% |
422,487 (+6.30%) |
Filing History |
| 2022-02-14 9:01 pm Sale |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-2,058,068 (Position Closed) |
Filing History |
| 2022-02-14 8:59 pm Sale |
2021-12-31 | 13G | Zymeworks Inc. ZYME |
PERCEPTIVE ADVISORS LLC | 3,679,845 6.600% |
-621,154 (-14.44%) |
Filing History |
| 2022-02-14 8:55 pm Unchanged |
2021-12-31 | 13G | ADMA Biologics, Inc. ADMA |
PERCEPTIVE ADVISORS LLC | 11,933,387 6.100% |
0 (Unchanged) |
Filing History |
| 2022-02-14 7:33 pm Sale |
2021-12-31 | 13G | VYNE Therapeutics Inc. VYNE |
PERCEPTIVE ADVISORS LLC | 134,756 4.500% |
-142,349 (-51.37%) |
Filing History |
| 2022-02-14 7:09 pm Sale |
2021-12-31 | 13G | AnaptysBio, Inc. ANAB |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-1,495,336 (Position Closed) |
Filing History |
| 2022-02-14 6:59 pm Sale |
2021-12-31 | 13G | Protara Therapeutics, Inc. TARA |
PERCEPTIVE ADVISORS LLC | 421,641 3.800% |
-186,903 (-30.71%) |
Filing History |
| 2022-02-14 6:59 pm Sale |
2021-12-31 | 13G | Outset Medical, Inc. OM |
PERCEPTIVE ADVISORS LLC | 124,226 4.000% |
-65,628 (-34.57%) |
Filing History |
| 2022-02-14 6:55 pm Unchanged |
2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
PERCEPTIVE ADVISORS LLC | 847,650 9.600% |
0 (Unchanged) |
Filing History |
| 2022-02-14 6:33 pm Purchase |
2021-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
PERCEPTIVE ADVISORS LLC | 5,407,798 7.000% |
735,962 (+15.75%) |
Filing History |
| 2022-02-14 6:31 pm Unchanged |
2021-12-31 | 13G | BCLS Acquisition Corp. BLSA |
PERCEPTIVE ADVISORS LLC | 1,000,000 6.700% |
0 (Unchanged) |
Filing History |
| 2022-02-14 5:46 pm Purchase |
2021-12-31 | 13G | POINT Biopharma Global Inc. PNT |
PERCEPTIVE ADVISORS LLC | 1,193,995 1.300% |
1,193,995 (New Position) |
Filing History |
| 2022-02-14 5:44 pm Purchase |
2021-12-31 | 13G | IVERIC bio, Inc. ISEE |
PERCEPTIVE ADVISORS LLC | 6,480,000 5.700% |
1,997,287 (+44.56%) |
Filing History |
| 2022-02-14 5:44 pm Sale |
2021-12-31 | 13G | Oncorus, Inc. ONCR |
PERCEPTIVE ADVISORS LLC | 999,812 3.900% |
-990,175 (-49.76%) |
Filing History |
| 2022-02-14 5:33 pm Sale |
2021-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
PERCEPTIVE ADVISORS LLC | 3,283,783 5.900% |
-409,733 (-11.09%) |
Filing History |
| 2022-02-14 5:31 pm Sale |
2021-12-31 | 13G | Frequency Therapeutics, Inc. FREQ |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-65,193 (Position Closed) |
Filing History |
| 2022-02-14 5:30 pm Purchase |
2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 2,927,565 9.900% |
1,350,084 (+85.58%) |
Filing History |